Carol Conrad
Clinical Trials
- NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients Recruiting
- #5902 Rare Genetic Disorders Study Recruiting
- Cystic Fibrosis Registry Recruiting
- Gilead FTI Study Recruiting
- HOLA CF Study Recruiting
- ISIS Study Recruiting
- Inspire Open-Label Extension study Recruiting
- Vertex 770-102 Study Recruiting
- Vertex 809-101 study Recruiting
- EPIC Observational Study No longer recruiting
- Inspire Phase 3: INS37217 Completed

